← 治験一覧に戻る
中等度から重度のアトピー性手足皮膚炎を有する成人および青年患者におけるデュピルマブの有効性および安全性を評価する研究（Liberty-AD-HAFT）
基本情報
- NCT ID
- NCT04417894
- ステータス
- 完了
- 試験のフェーズ
- 第3相
- 試験タイプ
- 介入
- 目標被験者数
- 133
- 治験依頼者名
- Regeneron Pharmaceuticals
概要
The primary objective of the study is to assess the efficacy of dupilumab on skin lesions in patients with atopic hand and foot dermatitis. The secondary objectives of the study are: * To assess the efficacy of dupilumab on various other domains (pruritus, pain, sleep loss, health related QoL, work life impairment) in patients with atopic hand and foot dermatitis * To evaluate the safety and tolerability of dupilumab administered to patients with atopic hand and foot dermatitis * To evaluate systemic exposure and immunogenicity of dupilumab in patients with atopic hand and foot dermatitis
対象疾患
Moderate to Severe Atopic Hand and Foot Dermatitis
介入
dupilumab(DRUG)
Placebo(DRUG)